Discontinuation report TARO-ATENOLOL
| Report ID | 115924 |
| Drug Identification Number | 02267993 |
| Brand name | TARO-ATENOLOL |
| Common or Proper name | ATENOLOL |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATENOLOL |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-05-12 |
| Remaining supply date | 2020-05-12 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-05-27 | French | Compare |
| v1 | 2020-05-27 | English | Compare |
Showing 1 to 2 of 2